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Abstract: In human epidermis, keratinocyte stem cells (KSC) are characterized by high 
levels of β1-integrin, resulting in the rapid adhesion to type IV collagen. Since epithelial 
tumors originate from KSC, we evaluated the features of rapidly adhering (RAD) 
keratinocytes derived from primary human squamous cell carcinoma of the skin (cSCC). 
RAD cells expressed higher levels of survivin, a KSC marker, as compared to non-rapidly 
adhering (NRAD) cells. Moreover, RAD cells proliferated to a greater extent and were 
more efficient in forming colonies than NRAD cells. RAD cells also migrated significantly 
better than NRAD cells. When seeded in a silicone chamber and grafted onto the back skin 
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of NOD SCID mice, RAD cells formed tumors 2–4 fold bigger than those derived from 
NRAD cells. In tumors derived from RAD cells, the mitotic index was significantly higher 
than in those derived from NRAD cells, while Ki-67 and survivin expression were more 
pronounced in RAD tumors. This study suggests that SCC RAD stem cells play a critical 
role in the formation and development of epithelial tumors. 
Keywords: squamous cell carcinoma; stem cells; β1-integrin; tumor formation; survivin; 
rapidly adhering cells; skin; tumorigenesis; differentiation  
 
1. Introduction  
Cutaneous squamous cell carcinoma (cSCC) is one of the most frequent skin cancers, second only 
to basal cell carcinoma (BCC) [1]. Although surgical removal of the lesion is the gold standard for 
cSCC management, often leading to complete eradication of the tumor, about 8% of cSCC patients 
undergo relapse and/or metastatic spread of the disease after treatment, suggesting that further studies 
on the mechanisms underlying cSCCs formation are needed.  
cSCCs develop following transformation of normal keratinocytes. Experiments based on chemical 
carcinogen retention show that only long-lived, slow cycling, non-differentiating keratinocytes are able 
to retain carcinogens, thus being at the origin of skin cancer formation [2]. Thus, keratinocyte stem 
cells (KSC), that possess all of these features, are believed to be the “SCC starting cells”, as they 
accumulate oncogenic mutations and cause tumor formation. This has been recently confirmed in mice 
expressing oncogenic KRasG12D and carrying a p53 deletion, in which both hair follicle bulge stem 
cells and their related progeny, but not matrix hair follicle transit amplifying cells, generated invasive 
SCC of the skin [3]. Although a definite marker for KSC is still lacking, a number of molecules have 
been used to isolate and identify these cells, including β1-integrin [4], and the membrane co-factor 
protein CD46, which sustains β1-integrin-mediated KSC adhesion [5], α6-integrin/CD71 [6], the  
anti-apoptotic protein survivin [7], and many others. We have previously shown that survivin identifies 
KSC and is downregulated when β1-integrin signal is disrupted [7].  
The hypothesis of tumors originating from stem cells has included two main concepts: on one side, 
tumors can develop from normal stem cells undergoing malignant transformation; on the other side, 
once tumors are formed, cells retaining stem cells features sustain their growth and are responsible for 
tumor recurrence and in some cases, distant metastasis [8,9]. The latter cells, named cancer stem cells 
(CSC), have been initially found in leukemia [10], and later in many solid tumors, including  
cSCC [11,12]. Recently, multiple populations of CSC in cSCC, characterized by differential 
expression of CD34 and β1-integrin, have been isolated. These cells are controlled by TGF-β and 
integrin⁄FAK signaling pathways [13]. In line with these findings, FAK, a tyrosine kinase downstream 
of integrin signaling, cooperates with β-catenin/Wnt pathway in regulating KSC behavior during early 
steps of skin carcinogenesis [14]. While these works highlight the importance of integrin signaling in 
skin tumor formation, recent findings also point at integrins as key players in human cSCC metastasis 
and invasion, acting through inhibition of apoptosis and differentiation and finally leading to 
expansion of tumor cells endowed with stem cells properties [15]. 
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In this work, we wanted to isolate from cSCC a subpopulation of primary keratinocytes with stem 
cell features, based on their high β1-integrin levels. We characterized these cells both in vitro and  
in vivo, with particular regard to their tumorigenic ability. Keratinocytes expressing high levels of  
β1-integrin and rapidly adhering to collagen IV (RAD) migrated to a greater extent, displayed higher 
colony forming efficiency and increased expression of stem cell-associated genes, as compared to non 
rapidly adhering (NRAD) cells. Moreover, when injected into immune-compromised mice, RAD cells 
generated bigger and more aggressive tumors, as compared to NRAD and bulk cells.  
2. Results and Discussion  
β1 integrin levels in mice serve as a discriminator between cSCC cells with different tumor-initiating 
potential [13]. While β1 integrin was used as a marker to enrich highly clonogenic SCC cells in vitro 
by selecting a population of rapidly adhering keratinocytes [16], a study providing partial 
characterization of SCC subpopulations did not address tumor initiation ability in vivo [17]. In the 
present study, we further enriched a population of rapidly adhering cells from cSCC primary cultures 
by improving the rapid adhesion to collagen IV method. The isolated subpopulations were then 
characterized both in vitro and in vivo, with particular regard to their tumorigenic ability. 
2.1. RAD Cells from Primary cSCC Cultures Are Abundant and Express High Levels of β1-Integrin 
Cultured cSCC cells display defective differentiation as compared to normal keratinocytes, and 
require feeder layers to be abundantly selected in vitro [18]. Once cultured for a few passages, cSCC 
cells become feeder-independent, yet are able to recapitulate tumor heterogeneity when inoculated  
in vivo, thus representing an excellent model for cSCC studies [19]. We therefore used primary  
cSCCs-derived cell cultures to analyze a population of stem-like cells in this tumor. 
Rapid adhesion to collagen-IV, a well-established method to rapidly and easily enrich KSC in 
human epidermis [4], has been recently applied to cSCC [16]. In the latter study, 20 min of adhesion to 
collagen IV was used to select a population enriched in highly clonogenic cells from SCC cell lines [16]. 
By reducing the adhesion period from 20 to 5 min, we were able to obtain a subpopulation further 
enriched in KSC from normal human skin [unpublished data]. We therefore used the 5-min method to 
isolate and characterize a population of rapidly adhering SCC keratinocytes from primary cSCC-derived 
cell cultures.  
We first observed that RAD/NRAD ratio was 0.45, when isolated from SCC at early passages. 
RAD cells expressed higher levels of β1-integrin than NRAD cells (Figure 1) consistently with high  
β1-integrin expression in cSCCs in vivo [20], thus confirming that shortening the adhesion time to 
collagen IV still allows efficient separation of cells. Interestingly, NRAD cells still display relatively 
high amount of β1-integrin, probably reflecting its overexpression in cSCCs cells when propagated in 
culture, as previously suggested [21]. At any rate, the choice to characterize SCC cell subtypes 
immediately after isolation prevents protein expression changes occurring in cell cultures.  
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Figure 1. β1-integrin levels in cSCC subpopulations. β1-integrin levels in RAD, NRAD and 
TOT cells were analyzed immediately after separation by Western blot. β-actin was used as 
loading control. Graph shows the average densitometry values normalized to actin,  
** p < 0.01. 
 
2.2. RAD from cSCC Are Highly Proliferating Cells In Vitro 
β1-integrin overexpressing cells from head and neck SCC cell lines, including cSCC, have higher 
clonogenic ability in vitro than cells with low β1-integrin levels [16]. In order to analyze the 
proliferative ability of cSCC subpopulations, we performed a crystal violet (CV) staining of RAD, 
NRAD and total cell cultures. Proliferation was significantly higher in RAD than in NRAD and total 
cells (Figure 2A). Stem cells are quiescent in vivo under homeostatic conditions, albeit retaining the 
ability to exit the quiescent state to repopulate and differentiate when necessary. When cultured, stem 
cells rapidly break the quiescence state and start to proliferate [22]. Consistent with CV assay, BrdU 
incorporation, an accurate determination of cells in S-phase of the cell cycle by flow cytometry, was 
higher in RAD than in NRAD and total cells (Figure 2B–D). These data confirm the highest 
proliferative activity of RAD cells in cSCC in vitro. 
Figure 2. Proliferative ability of cSCCs subpopulations in vitro. (A) RAD, NRAD and 
TOT cells ability to proliferate in vitro was evaluated by CV staining; (B) RAD, NRAD 
and TOT cells were cultured for 72 h. BrdU incorporation was then evaluated by using 
FITC BrdU Flow Kit and analyzed by flow cytometry 72 h after the seeding. ** p < 0.01; 
(C) Monoparametric histograms showing BrdU incorporation by FACS; (D) Density dot 
plots showing BrdU incorporation by FACS. 
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Figure 2. Cont. 
 
2.3. RAD cSCC Cells Are Less Differentiated and Express High Levels of Survivin  
Stem cells are undifferentiated cells that give raise to a progeny of transit amplifying cells, which in 
turn undergo terminal differentiation after a few rounds of division [23]. To further characterize RAD 
cells, we evaluated the expression of several epidermal differentiation markers in cSCC subpopulations 
(Figure 3A,B). E-FABP and involucrin were less expressed in RAD than in NRAD cells. Similarly to 
involucrin, E-FABP is expressed in terminally differentiated keratinocytes and induces differentiation 
in normal and psoriatic cells in vitro [24]. In SCCs, both involucrin and E-FABP mark differentiated 
keratinocytes [25]. Therefore, overexpression of these markers in NRAD cells suggests that NRAD are 
highly differentiated cells, while RAD keratinocytes represent a less differentiated subpopulation in the 
tumor. On the other hand, survivin, a marker of normal KSC in vitro, was overexpressed in RAD 
keratinocytes when compared to NRAD and total cells. Survivin overexpression has been reported in 
tumors, in fetal tissues and recently in stem cells from adult tissues, in both normal and pathologic 
conditions [26,27]. Consistently, survivin is involved in the CSC resistance mechanisms against 
chemo- and radio-therapy [28]. Moreover, regulation of survivin expression decides the balance 
between survival and apoptosis in neural stem cells and glioma CSC [29]. Finally, vascular endothelial 
growth factor (VEGF) is slightly but significantly increased in RAD cells, in line with the recent 
observation of this factor being upregulated in CSC [30]. Taken together, these data suggest that RAD 
cells represent a population of stem-like cells in primary cultures of cSCC.  
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Figure 3. Expression of stem cell and differentiation markers in RAD, NRAD and TOT cells 
from cSCC. (A) Cells were analyzed immediately after separation, and levels of markers were 
determined by Western blot analysis. β-actin was used as loading control; (B) Bar graphs 
show the average densitometry values normalized to actin. * p < 0.05; ** p < 0.01. 
 
2.4. RAD Cells from cSCC Display High Colony Forming Efficiency and Increased Expression of Stem 
Cell-Associated Genes 
Colony forming efficiency (CFE) assay assesses the capability of cells to generate progeny. It has 
been employed to evaluate clonogenic ability of cancer cell subtypes and as a surrogate to analyze 
putative enrichments of stem cell-like cells [16,31]. CFE analysis of cells re-plated at clonal density 
immediately after separation showed that RAD cells have a significantly higher CFE as compared to 
NRAD and total cells (Figure 4A). This is in line with the highest total cell output and proliferation 
observed in RAD cells, as shown in Figure 2. In addition, the stem cell markers Nanog, Oct4 and Sox-2 
were significantly more expressed in RAD cells, further confirming the stem cell nature of these cSCC 
cells (Figure 4B). Interestingly, the transcription factor Sox-2 directly increases survivin levels in 
neural stem cells [26], suggesting that it may contribute to sustain RAD stemness also by upregulating 
survivin in cSCC cells.  
Figure 4. Analysis of stem-cell features in RAD and NRAD cells in vitro. (A) Clonal 
growth assessment of cSCC subpopulations by CFE. CFE was performed in triplicate in three 
independent experiments and quantification is shown in the upper panel. At the bottom, 
representative pictures of CFE obtained by growing cells at clonal density and stained with CV 
are shown; (B) mRNA expression of Nanog, Oct4 and Sox-2 by Real Time PCR. The different 
levels of gene expression in RAD vs. NRAD cells are shown. * p < 0.05; ** p < 0.01. 
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CD133 has been successfully used to identify and separate CSC in primary human cSCC [32]. We 
therefore evaluated CD133 expression in cultured cSCC cells by flow cytometry and Western blot. 
While Head and Neck SCC cell lines express variable levels of this marker in almost 100% of the 
cells, primary cSCC cultures do not express detectable levels of this protein (data not shown). CD133 
is a very sensitive antigen that may be altered and not detectable in culture [33]. 
2.5. RAD Cells Migrate to a Greater Extent than NRAD and Total SCC Keratinocytes 
Along with tumorigenic ability, CSC or cells with stem-cell features may also retain the capacity to 
migrate and generate distant metastasis. Unlike most BCCs, cSCCs display a high risk to metastasize. 
Since the ability of cells to form metastasis reflects increased cell motility, we assessed cell migration 
through a scratching assay. To rule out the possibility that migrated cells were indeed proliferating 
keratinocytes, cells were pretreated with the mitosis inhibitor mitomycin C. RAD cells possess a 
higher migration ability than NRAD and total cells (Figure 5A,B). As β1-integrin and survivin are 
highly expressed in RAD cells and are involved in keratinocyte migration [34], [unpublished results], 
they might sustain this RAD cell ability. 
Figure 5. Migration ability of cSCCs subpopulations. The migration of RAD, NRAD and 
TOT cells was determined by scratching assay. Cells were fixed and stained, and the 
number of migrated cells to the scratched surface area was counted. (A) Number of 
migrated cells expressed as the mean + SD from triplicate experiments, * p < 0.05, ** p < 0.01; 
(B) Representative images of migrated cSCCs subpopulations in the scratching assay.  
 
2.6. RAD Cells from cSCCs Are Tumorigenic In Vivo  
Although “rapid adhesion to collagen IV” is a useful method to isolate cSCC cells with CSC-like 
properties, CFE and stem cell markers expression do not guarantee the repopulation ability of the cells, 
when grafted into immune-deficient mice. In order to evaluate the tumorigenic ability of cSCC 
subpopulations, we grafted RAD and NRAD cells onto NOD-SCID mice, together with primary 
human fibroblasts, and monitored tumor growth over time. Given the strong dependence of skin tumor 
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cells from the tumor microenvironment, the xenograft model employed in this study satisfies the 
requirements for the propagation of skin tumors in vivo [3,30]. RAD cells generated tumors 2–4 times 
bigger (in 100% of mice) than those formed by NRAD keratinocytes (in 95% of mice) (Figure 6A,B). 
The ability of RAD cells to form bigger tumors suggests that the RAD population is enriched either in 
tumor-initiating cells or rapidly growing/aggressive SCC keratinocytes, as compared to NRAD, thus 
retaining greater tumorigenic potential. However, since NRAD cells possess tumorigenic ability, albeit 
developing smaller tumors, high-β1-integrin expression is not an exclusive requirement for the 
selection of tumorigenic cells in cSCC. Hematoxilin and eosin staining confirmed that RAD-derived 
tumors are more aggressive and invasive than NRAD-derived ones. Pan-cytokeratin staining of RAD 
and NRAD derived tumors confirms the presence of epithelial cells in both tumor types (Figure 6C). 
While the tumorigenic ability of SCC cells separated by β1-integrin levels through collagen IV 
adhesion had not been previously shown, β1-integrin is considered as a key player in cSCC 
tumorigenesis. In fact, β1-integrin blockade reduces tumorigenesis in vivo [35], while mutations in the 
β1-integrin gene lead to malignant conversion of skin tumors [36]. This study only evaluated the 
tumorigenic ability of RAD and NRAD cells without analyzing their self-renewal ability through serial 
transplantation experiments. Therefore, we cannot address whether β1-integrin is a marker of CSCs  
in cSCCs. 
Figure 6. Tumorigenic ability of cSCC cells subpopulations in vivo. (A) Representative 
picture of RAD and NRAD-derived tumors formed by xenografting cSCC keratinocytes 
onto NOD/SCID mice; (B) Size of RAD and NRAD derived tumors as measured in three 
independent experiments. * p < 0.05, ** p < 0.01; (C) Hematoxilin & Eosin and  
Pan-cytokeratin (CK) staining of RAD and NRAD-derived tumors. Scale bars = 200 μm.  
 
Int. J. Mol. Sci. 2013, 14 19548 
 
 
2.7. RAD-Derived Tumors Display Most Aggressive Features  
To further characterize RAD-derived tumors, we calculated the mitotic index (MI) in RAD and 
NRAD-derived tumors. MI is often associated with tumor histological grades and cell proliferation since it 
predicts patient survival and resistance to therapies in many cancerous tissues. In RAD-derived tumors, MI 
was 2,68 fold higher than in NRAD derived lesions (RAD: 8.82+/−1.56, NRAD 3.29+/−0.97) (Figure 7A). 
Sections were also stained with survivin and Ki67 to evaluate cell proliferation. As previously 
reported, survivin is mainly localized in the nuclei of cancer cells, while it almost exclusively localizes 
in the cytoplasm of normal epithelial cells [7,37]. Cells with either survivin or Ki67 nuclear staining were 
more numerous in RAD than in NRAD tumors (Figure 7B). Ki67 overexpression in RAD-derived tumors 
is consistent with increased MI, while survivin increase in RAD tumors is in line with its role in cell 
cycle regulation and cell division [38]. The concomitant overexpression of survivin and Ki67 along 
with the high MI in RAD-derived tumors strongly suggests the superior aggressiveness of  
RAD-derived tumors. Survivin is more pronounced in less differentiated cSCC cells (manuscript in 
preparation). In addition, survivin is mainly localized in suprabasal epidermal layers in RAD tumors, while 
remaining in basal and immediately suprabasal cells in NRAD tumors. Along this line, the differentiation 
markers K10, E-FABP and involucrin were more expressed in NRAD than in RAD-derived tumors 
(Figure 7C). 
All together, these findings suggest that RAD cells are poorly differentiated, highly proliferating 
and tumorigenic cSCC cells that in turn, generate very aggressive tumors. This seems to suggest that 
cells expressing high levels of β1-integrin and stem cell features determine higher tumor 
aggressiveness in cSCC. 
Figure 7. RAD and NRAD-derived tumor characterization. (A) Mitotic Index representing 
the number of cells undergoing mitosis over total cells were counted in RAD and  
NRAD-derived tumors ** p < 0.01; (B) Survivin and Ki67 expression in RAD and  
NRAD-derived tumors by immunohistochemistry. Scale bar = 200 μm; (C) K10, E-FABP and 
involucrin expression in RAD and NRAD-derived tumors by immunohistochemistry.  
Scale bar = 200 μm. 
 
Int. J. Mol. Sci. 2013, 14 19549 
 
 
Figure 7. Cont. 
 
3. Experimental Section  
3.1. Isolation of Primary Keratinocytes from cSCCs Tissues 
Tumor samples from ten human cSCC patients were surgically removed and immediately stored in 
a sterile test tube containing medium and antibiotics. All tumor samples were collected with written 
informed consent of patients, according to the Declaration of Helsinki after approval of the Modena 
Medical Ethical Committee. Tumor tissues were washed with PBS without calcium and magnesium, 
cut into small fragments and digested in DMEM containing 200 U/mL type I collagenase, 200 U/mL 
dispase and 70 U/mL DNase shaking for 2 h at 37 °C. The digested top tissue mixture was then filtered 
and centrifuged to collect the cells. Total cells were then seeded onto 3T3 feeder layers as previously 
described [39] and primary and secondary cell cultures were obtained. 
For RAD and NRAD cells isolation, collagen IV coated plates were prepared by seeding a human 
placenta-derived collagen IV solution (100 μg/mL, Sigma-Aldrich, St. Louis, MO, USA). Total cells 
from cSCC cultures, either at passage 0 or 1, were seeded on collagen IV pre-coated dishes for 5 min. 
Cells adhering within 5 min represent RAD cSCC keratinocytes; in order to analyze RAD and NRAD 
cellular morphology, after cell separation, NRAD and TOT cells were collected and seeded on a dish 
of the same size as the one used for the separation; pictures have been taken within 10 min from the 
separation process. In order to avoid changes in the expression pattern due to prolonged cell cultures, 
immediately after separation NRAD cells were collected, while RAD cells were detached by 
incubating them with a trypsin/EDTA 0.05%/0.02% solution for 5–10 min at 37 °C. For in vitro 
proliferation/viability assays, cells were maintained in culture with serum-free keratinocyte growth 
medium (KGM) until they reached the desired confluency. 
3.2. Western Blotting 
Total proteins were extracted with RIPA lysis buffer containing protease inhibitors. Equal amounts 
of protein from each sample were run through a 6%–18% SDS–PAGE gel and transferred onto a 
nitrocellulose membrane. Membranes containing protein were incubated overnight at 4 °C with the 
following antibodies: anti-survivin rabbit polyclonal (1:1000; Novus Biologicals, Bloomington, MN, 
USA), or goat anti-human FABP5 (1:1000; R&D Systems, Inc. Minneapolis, MN, USA), or mouse 
mAB anti-human involucrin (1:6000; Sigma-Aldrich, St. Louis, MO, USA), or anti-human β1-integrin 
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(1:500; Santa Cruz Biotechnology, inc. Santa Cruz, CA, USA) or anti-human β-actin (1:5000;  
Sigma-Aldrich, St. Louis, MO, USA). After 3 washes with a PBS/tween solution, membranes were 
then incubated with secondary antibodies for 45 min at room temperature. Bands were then visualized 
with chemiluminescence detection system (Amersham Biosciences UK Limited, Little Chalfont 
Buckinghamshire, UK). 
3.3. Detection of Cell Viability by Crystal Violet Staining  
cSCC RAD, NRAD and bulk cells (5000/well) were seeded in a 96-wells plate and incubated at 37 °C 
for 72 h. Subsequently, the supernatants were discarded and the remaining viable adherent cells were 
fixed with 4% buffered paraformaldehyde and stained with a solution of 0.4% crystal violet in 100% 
methanol for 30 min. The plate was then rinsed with water and air-dried. The absorbance of each well 
was measured at 590 nm with a microplate reader. The results are expressed as optical density units 
(OD). Results are calculated as the mean SD of three different experiments. The OD of the samples 
was plotted against time. 
3.4. BrdU Proliferation Assay 
The BrdU proliferation assay for RAD and NRAD cells from cSCCs cultures was carried out using 
the FITC BrdU Flow Kit (BD Biosciences, San Jose, CA, USA). Isolated cells were re-seeded and 
incubated with Bromodeoxyuridine (BrdU, 1 mM) for 24 h. BrdU incorporating cells (S phase) were 
analyzed 72 h after the seeding following manufacturer’s instructions. Briefly, cells were fixed and 
permeabilized by BD Cytofix/Cytoperm Buffer. After 40 min incubation with DNase at 37 °C, cells 
were stained with FITC-conjugated anti-BrdU monoclonal antibody. 7-aminoactinomycin (7-AAD) was 
added to each sample right before flow Cytometry analysis (Epics XL flow cytometer (Coulter Electronics 
Inc., Hi-aleah, FL, Beckman Coulter, Fullerton, CA, USA, http://www. beckmancoulter.com). The 
results are expressed as the % of cells in each phase of the cell cycle and are calculated as the mean SD 
of three different experiments. 
3.5. Colony Forming Efficiency (CFE) 
Keratinocytes were cultured on a feeder layer composed of mytomicin C (Sigma-Aldrich, St. Louis, 
MO, USA)-treated 3T3 cells at a density of 100 cells per dish. Fourteen days later, dishes were fixed 
with 10% buffered formalin and stained with crystal violet. Colonies that contained more than 50 cells 
were counted and CFE was calculated. The colony number was expressed as a percentage of the number of 
cells plated in each dish. Results are calculated as the mean ± SD of three different experiments. 
3.6. Scratching Assay 
cSCC keratinocytes were seeded in dishes (25 × 103 cells/cm2) and treated with 5 μg/mL of 
mitomycin C (Sigma-Aldrich, St. Louis, MO, USA) for 2 h. After 2 washes with sterile PBS, each well 
was then drawn along the cell monolayer with a sterile plastic tip. Plates were then washed twice with 
PBS and incubated in serum-free medium. Cells were then monitored at 48 h. The result of each 
experiment was expressed as the % of the mean of migrated cells from six different areas. The final 
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results are expressed as the mean ± SD of three different experiments. Student’s t-test was performed 
for comparison of the means. 
3.7. H&E Staining and Mitotic Index Calculation 
Tumors were removed from animals, placed in 4% buffered formalin for no more than 24 h, and 
then embedded in paraffin. Serial tissue sections (4 μm thick) were deparaffinized, hydrated in xylene 
and graded alcohol solutions. For H&E stains, Mayer hematoxylin and Eosin Y Alcoholic were used. 
Staining times were 5 min for hematoxylin and 1 min for eosin. Slides were covered with coverslips 
with the addition of aqueous mount. The mitotic index was calculated and expressed as the ratio 
between the number of cells in mitosis and the total number of cells on H&E sections. 
3.8. In Vivo Tumorigenesis  
cSCC tumors were generated as previously shown [40]. Briefly, cSCC subpopulations were 
separated from SCC13 keratinocytes. 1–5 × 106 SCC13 keratinocytes were immediately mixed with  
1 × 106 neonatal dermal fibroblasts, and injected into silicon chambers (Renner GMBH, Darmstadt, 
Germany) surgically implanted on the dorsal fascia of recipient NOD/SCID mice. The upper part of 
the chamber was removed one week after injection, in order to allow air exposure of the graft. At day 
14 from implantation, the chamber was entirely removed. Reconstituted skin tumors were typically 
observed within 1–3 months post-grafting. Tumor growth was monitored twice/week and measured 
with a caliper. Tumors were harvested when they reached 1 cm diameter size for histological analysis, 
mitotic index measure and immunohystochemistry. Tumor volume was calculated by the formula 
(longest diameter) × (shortest diameter)2/2.  
3.9. Immunohistochemistry  
Tumor sections were obtained from formalin fixed-paraffin embedded RAD and NRAD-derived 
tumors. The staining was performed using the UltraVision LP Detection System AP Polymer & Fast 
Red Chromogen assay (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturer’s 
instructions. Briefly, slides were treated with Ultra V Block and samples were incubated with  
anti-CK10 (1:200; Epitomics, Burlingame, CA, USA) or anti-E-FABP (1:200; R&D systems, 
Minneapolis, MN, USA), or anti-Ki67 (1:200; Epitomics, Burlingame, CA, USA), or anti-keratin 
(ready to use; Cell Marque), or anti-involucrin (1:500; Sigma-Aldrich, St. Louis, MO, USA) for 1 hat 
room temperature. After washes in PBS, Primary Antibody Enhancer (Thermo Fisher Scientific, 
Waltham, MA, USA) was added for 20 min at room temperature, followed by incubation with AP 
Polymer anti-mouse/rabbit IgG for 30 min at room temperature. Slides were stained with Fast Red 
using Naphthol Phosphate as substrate. Samples were analyzed under a conventional optical 
microscope (Zeiss Axioskope 40, Carl Zeiss, Jena, Germany).  
For survivin detection, the slides were first boiled in citrate buffer, pH6, for 30 min at 98 °C. 
samples were then incubated with anti- survivin rabbit polyclonal antibody (1:300; Novus, 
Bloomington, MN, USA) for 32 min at 37 °C. For immunohistochemistry staining, we used  
3,3' Diaminobenzidine (DAB) as cromogen. 
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3.10. Real Time PCR 
Total RNA was extracted from primary RAD and NRAD cSCC keratinocytes by using TRI 
Reagent, performed as described by the manufacturer (Sigma-Aldrich, St. Louis, MO, USA). cDNA 
was synthesized from 500 ng of total RNA as described by the manufacturer (Roche). Each cDNA 
generated was amplified by quantitative Real Time PCR in a reaction mixture containing 1× iQ™ 
SYBR® Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA), 10 ng of cDNA, and  
the following primers: Oct-4: 5'-AGCAAAACCCGGAGGAGT-3' and  
5'-CCACATCGGCCTGTGTATATC-3', Sox-2: 5'-TTGCTGCCTCTTTAAGACTAGGA-3' and  
5'-CTGGGGCTCAAACTTCTCTC-3', Nanog: 5'-TGAACCTCAGCTACAAACAG-3' and  
5'-TGGTGGTAGGAAGAGTAAAG-3', GAPDH: 5'-AGCCACATCGCTCAGACA-3' and  
5'-GCCCAATACGACCAAATCC-3'. The expression of each gene was calculated by the comparative 
threshold cycle method (2−ΔΔCt). Briefly, the average Ct value of GAPDH for every sample was 
subtracted from the Ct value for each target gene, resulting in the ΔCt value. The expression level of 
each gene is shown relative to that of RAD cells (calibrator). The comparative cycle threshold (ΔΔCt) 
results from the difference between (ΔCt each population) minus (ΔCt calibrator). PCR was carried out 
at least three times for each sample, and the experiment was performed at least three times.  
4. Conclusions  
Here we show that tumor cells isolated from primary cSCC based on their highest β1-integrin 
expression (RAD) have stem cell features. In vivo, RAD cells generate large and aggressive tumors 
characterized by elevated mitotic index and hyperproliferation. As nuclear survivin, a KSC marker, is 
abundantly expressed in RAD-derived tumors, we speculate that survivin plays an important role in the 
development of cSCC, thus confirming that this tumor is derived from KSC. Functional studies are 
needed not only to fully understand the role of survivin in tumor formation, but also to determine 
whether survivin, similarly to β1-integrin, is involved in CSC activities, being ultimately responsible 
for tumor recurrence and metastasis in cSCC.  
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